Restricted accessResearch articleFirst published online 2020-12
Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson’s Disease and Cross-Cultural Comparison
The Montreal Cognitive Assessment (MoCA) is one of the most common screening instruments for mild cognitive impairment. However, the standard MoCA is approximately two times longer to administer than the Mini-Mental State Examination. A total of 699 Czech and 175 American participants received the standard MoCA Czech and English versions and in the clinical part, a sample of 102 nondemented patients with Parkinson’s disease (PD). We created a validated Czech short version (s-MoCA-CZ) from the original using item response theory. As expected, s-MoCA-CZ scores were highly correlated with the standard version (Pearson r = .94, p < .001). s-MoCA-CZ also had 80% classification accuracy in the differentiation of PD mild cognitive impairment from PD without impairment. The s-MoCA-CZ, a brief screening tool, is shorter to administer than the standard MoCA. It provides high-classification accuracy for PD mild cognitive impairment and is equivalent to that of the standard MoCA-CZ.
AarslandD.AndersenK.LarsenJ. P.LolkA.Kragh-SorensenP. (2003). Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study. Archives of Neurology, 60, 387-392.
AarslandD.LarsenJ. P.KarlsenK.LimN. G.TandbergE. (1999). Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. International Journal of Geriatric Psychiatry, 14, 866-874.
4.
BentonA. L.HamsherK.SivanA. B. (1994). Multilingual Aphasia Examination (3rd ed.). San Antonio, TX: Psychological Corporation.
5.
BezdicekO.LibonD. J.StepankovaH.PanenkovaE.LukavskyJ.GarrettK. D.. . . KopecekM. (2014). Development, validity, and normative data study for the 12-word Philadelphia Verbal Learning Test [czP(r)VLT-12] among older and very old Czech adults. Clinical Neuropsychologist, 28, 1162-1181. doi:10.1080/13854046.2014.952666
6.
BezdicekO.MichalecJ.NikolaiT.StepankovaH.PanenkovaE.HarsaP.. . . RuzickaE. (2014). Validity of the Montreal Cognitive Assessment in the detection of Mild Cognitive Impairment in Parkinson’s disease. Ceska a Slovenska Neurologie a Neurochirurgie, 77, 47-53.
7.
BezdicekO.MotákL.AxelrodB. N.PreissM.NikolaiT.VyhnálekM.. . . RůžičkaE. (2012). Czech version of the Trail Making Test: Normative data and clinical utility. Archives of Clinical Neuropsychology, 27, 906-914.
8.
BezdicekO.MotákL.SchretlenD. J.PreissM.AxelrodB. N.NikolaiT.. . . RůžičkaE. (2016). Sociocultural and language differences on the Trail Making Test. Archives of Assessment Psychology, 6, 33-48.
9.
BezdicekO.NikolaiT.MichalecJ.RůžičkaF.HavránkováP.RothJ.. . . RůžičkaE. (2017). The diagnostic accuracy of Parkinson’s disease mild cognitive impairment battery using the Movement Disorder Society Task Force criteria. Movement Disorders Clinical Practice, 4, 237-244. doi:10.1002/mdc3.12391
10.
BezdicekO.StepankovaH.Martinec NovakovaL.KopecekM. (2016). Toward the processing speed theory of activities of daily living in healthy aging: Normative data of the Functional Activities Questionnaire. Aging Clinical and Experimental Research, 28, 239-247. doi:10.1007/s40520-015-0413-5
11.
BezdicekO.SulcZ.NikolaiT.StepankovaH.KopecekM.JechR.RuzickaE. (2017). A parsimonious scoring and normative calculator for the Parkinson’s disease mild cognitive impairment battery. The clinical Neuropsychologist, 1231-1247. doi:10.1080/13854046.2017.1293161
12.
BrayneC.FoxC.BoustaniM. (2007). Dementia screening in primary care: Is it time?Journal of the American Medical Association, 298, 2409-2411. doi:10.1001/jama.298.20.2409
13.
ChoiS. W. (2009). Firestar: Computerized adaptive testing simulation program for polytomous item response theory models. Applied Psychological Measurement, 33, 644-645. doi:10.1177/0146621608329892
14.
Dalrymple-AlfordJ. C.MacAskillM. R.NakasC. T.LivingstonL.GrahamC.CrucianG. P.. . . AndersonT. J. (2010). The MoCA: Well-suited screen for cognitive impairment in Parkinson disease. Neurology, 75, 1717-1725. doi:10.1212/WNL.0b013e3181fc29c9
15.
DeLongE. R.DeLongD. M.Clarke-PearsonD. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics, 44, 837-845.
16.
DirnbergerG.JahanshahiM. (2013). Executive dysfunction in Parkinson’s disease: A review. Journal of Neuropsychology, 7, 193-224. doi:10.1111/jnp.12028
17.
DorseyE. R.ConstantinescuR.ThompsonJ. P.BiglanK. M.HollowayR. G.KieburtzK.. . . TannerC. M. (2007). Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology, 68, 384-386. doi:10.1212/01.wnl.0000247740.47667.03
18.
DuboisB.BurnD.GoetzC.AarslandD.BrownR. G.BroeG. A.. . . EmreM. (2007). Diagnostic procedures for Parkinson’s disease dementia: Recommendations from the Movement Disorder Society Task Force. Movement Disorders, 22, 2314-2324. doi:10.1002/mds.21844
19.
EmbretsonS. E.ReiseS. P. (2000). Item response theory for psychologists. Mahwah, NJ: Lawrence Erlbaum.
20.
EmreM.AarslandD.AlbaneseA.ByrneE. J.DeuschlG.De DeynP. P.. . . LaneR. (2004). Rivastigmine for dementia associated with Parkinson’s disease. New England Journal of Medicine, 351, 2509-2518. doi:10.1056/NEJMoa041470
21.
EmreM.AarslandD.BrownR.BurnD. J.DuyckaertsC.MizunoY.. . . DuboisB. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22, 1689-1707. doi:10.1002/mds.21507
22.
FawcettT. (2006). An introduction to ROC analysis. Pattern Recognition Letters, 27, 861-874. doi:10.1016/j.patrec.2005.10.010
23.
FenglerS.KesslerJ.TimmermannL.ZapfA.ElbenS.WojteckiL.. . . KalbeE. (2016). Screening for cognitive impairment in Parkinson’s disease: Improving the diagnostic utility of the MoCA through subtest weighting. PLoS ONE, 11(7), e0159318. doi:10.1371/journal.pone.0159318
24.
FernandezA. L.MarcopulosB. A. (2008). A comparison of normative data for the Trail Making Test from several countries: Equivalence of norms and considerations for interpretation. Scandinavian Journal of Psychology, 49, 239-246. doi:10.1111/j.1467-9450.2008.00637.x
25.
FlorkowskiC. M. (2008). Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: Communicating the performance of diagnostic tests. Clinical Biochemist. Reviews, 29(Suppl. 1), S83-S87.
26.
FolsteinM. F.FolsteinS. E.McHughP. R. (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
27.
GillD. J.FreshmanA.BlenderJ. A.RavinaB. (2008). The Montreal Cognitive Assessment as a screening tool for cognitive impairment in Parkinson’s disease. Movement Disorders, 23, 1043-1046. doi:10.1002/mds.22017
28.
GuttmanL. (1945). A basis for analyzing test-retest reliability. Psychometrika, 10, 255-282.
29.
HendersonE. J.ChuH.GauntD. M.WhoneA. L.Ben-ShlomoY.LyellV. (2016). Comparison of Test Your Memory and Montreal Cognitive Assessment measures in Parkinson’s disease. Parkinson’s Disease, 2016, 1012847. doi:10.1155/2016/1012847
30.
HoopsS.NazemS.SiderowfA. D.DudaJ. E.XieS. X.SternM. B.WeintraubD. (2009). Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology, 73, 1738-1745. doi:10.1212/WNL.0b013e3181c34b47
31.
HortonD. K.HynanL. S.LacritzL. H.RossettiH. C.WeinerM. F.CullumC. M. (2015). An abbreviated Montreal Cognitive Assessment (MoCA) for dementia screening. The Clinical Neuropsychologist, 29, 413-425. doi:10.1080/13854046.2015.1043349
32.
HughesA. J.DanielS. E.KilfordL.LeesA. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. Journal of Neurology Neurosurgery & Psychiatry, 55, 181-184.
33.
JankovicJ. (2008). Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology Neurosurgery & Psychiatry, 79, 368-376. doi:10.1136/jnnp.2007.131045
34.
KopecekM.BezdicekO.SulcZ.LukavskyJ.StepankovaH. (2016). Montreal Cognitive Assessment and Mini-Mental State Examination reliable change indices in healthy older adults. International Journal of Geriatric Psychiatry, 32, 868-875. doi:10.1002/gps.4539
35.
KopecekM.StepankovaH.LukavskyJ.RipovaD.NikolaiT.BezdicekO. (2017). Montreal Cognitive Assessment (MoCA): Normative data for old and very old Czech adults. Applied Neuropsychology: Adult, 24, 23-29. doi:10.1080/23279095.2015.1065261
36.
LitvanI.GoldmanJ. G.TrosterA. I.SchmandB. A.WeintraubD.PetersenR. C.. . . EmreM. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27, 349-356. doi:10.1002/mds.24893
37.
LordF. M. (1980). Applications of item response theory to practical testing problems. Hillsdale, NJ: Routledge.
38.
MooreT. M.ScottJ. C.ReiseS. P.PortA. M.JacksonC. T.RuparelK.. . . GurR. C. (2015). Development of an abbreviated form of the Penn Line Orientation Test using large samples and computerized adaptive test simulation. Psychological Assessment, 27, 955-964. doi:10.1037/pas0000102
39.
NasreddineZ. S.PhillipsN. A.BedirianV.CharbonneauS.WhiteheadV.CollinI.. . . ChertkowH. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of American Geriatric Society, 53, 695-699. doi:10.1111/j.1532-5415.2005.53221.x
40.
NazemS.SiderowfA. D.DudaJ. E.HaveT. T.ColcherA.HornS. S.. . . WeintraubD. (2009). Montreal Cognitive Assessment performance in patients with Parkinson’s disease with “normal” global cognition according to Mini-Mental State Examination score. Journal of American Geriatric Society, 57, 304-308. doi:10.1111/j.1532-5415.2008.02096.x
41.
NikolaiT.ŠtěpánkováH.MichalecJ.BezdíčekO.HorákováK.MarkováH.. . . KopečekM. (2015). Testy verbální fluence: Česká normativní studie pro osoby vyššího věku [Verbal fluency tests: Czech normative study for older persons]. Ceska a Slovenska Neurologie a Neurochirurgie, 78, 292-299.
42.
Ostrosky-SolisF.CansecoE.QuintanarL.NavarroE.MenesesS.ArdilaA. (1985). Sociocultural effects in neuropsychological assessment. International Journal of Neuroscience, 27, 53-66.
43.
OwenA. M.JamesM.LeighP. N.SummersB. A.MarsdenC. D.QuinnN. P.. . . RobbinsT. W. (1992). Fronto-striatal cognitive deficits at different stages of Parkinson’s disease. Brain, 115, 1727-1751.
44.
PanenkováE.KopečekM.LukavskýJ. (2016). Item analysis and possibility to abbreviate the Montreal Cognitive Assessment. Czech and Slovak Psychiatry, 112, 63-69.
45.
PigottK.RickJ.XieS. X.HurtigH.Chen-PlotkinA.DudaJ. E.. . . WeintraubD. (2015). Longitudinal study of normal cognition in Parkinson disease. Neurology, 85, 1276-1282. doi:10.1212/wnl.0000000000002001
46.
PirogovskyE.SchiehserD. M.ObteraK. M.BurkeM. M.LessigS. L.SongD. D.. . . FiloteoJ. V. (2014). Instrumental activities of daily living are impaired in Parkinson’s disease patients with mild cognitive impairment. Neuropsychology, 28, 229-237. doi:10.1037/neu0000045
47.
RebanJ. (2006). Montrealský kognitivní test (MoCA): Přínos k diagnostice demence [Montreal Cognitive Assessment (MoCA): Contribution to diagnosis of predementia]. Česká Geriatrická Revue, 4, 224-229.
48.
RoalfD. R.MobergP. J.XieS. X.WolkD. A.MoelterS. T.ArnoldS. E. (2013). Comparative accuracies of two common screening instruments for classification of Alzheimer’s disease, mild cognitive impairment, and healthy aging. Alzheimer’s & Dementia, 9, 529-537. doi:10.1016/j.jalz.2012.10.001
49.
RoalfD. R.MooreT. M.Mechanic-HamiltonD.WolkD. A.ArnoldS. E.WeintraubD. A.MobergP. J. (2017). Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination. Alzheimer’s & Dementia, 13, 947-952. doi:10.1016/j.jalz.2017.01.015
50.
RoalfD. R.MooreT. M.WolkD. A.ArnoldS. E.Mechanic-HamiltonD.RickJ.. . . MobergP. J. (2016). Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease. Journal of Neurology Neurosurgery & Psychiatry, 87, 1303-1310. doi:10.1136/jnnp-2015-312723
51.
RossettiH. C.LacritzL. H.CullumC. M.WeinerM. F. (2011). Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology, 77, 1272-1275. doi:10.1212/WNL.0b013e318230208a
52.
SamejimaF. (1969). Estimation of latent ability using a response pattern of graded scores. Psychometrika, 34(4pt. 2), 100.
53.
SchragA.JahanshahiM.QuinnN. (2000). What contributes to quality of life in patients with Parkinson’s disease?Journal of Neurology Neurosurgery & Psychiatry, 69, 308-312.
54.
SolomonS. R.SawilowskyS. S. (2009). Impact of rank-based normalizing transformations on the accuracy of test scores. Journal of Modern Applied Statistical Methods, 8, 448-462.
55.
SteinhausH. (1956). Sur la division des corps matériels en parties [On the division of material elements in parts]. Bulletin of the Polish Academy of Sciences, 4, 801-804.
56.
StepankovaH.NikolaiT.LukavskyJ.BezdicekO.VrajovaM.KopecekM. (2015). Mini-Mental State Examination: Czech Normative Study. Ceska a Slovenska Neurologie a Neurochirurgie, 78, 57-63.
57.
TestaS. M.WinickiJ. M.PearlsonG. D.GordonB.SchretlenD. J. (2009). Accounting for estimated IQ in neuropsychological test performance with regression-based techniques. Journal of the International Neuropsychological Society, 15, 1012-1022.
58.
van de VijverF.TanzerN. (2004). Bias and equivalence in cross-cultural assessment: An overview. Revue Européenne de Psychologie Appliquée, 2, 119-135.
59.
VossiusC.LarsenJ. P.JanvinC.AarslandD. (2011). The economic impact of cognitive impairment in Parkinson’s disease. Movement Disorders, 26, 1541-1544. doi:10.1002/mds.23661
60.
WainerH.DoransN. J.EignorD.FlaugherR.GreenB. F.MislevyR. J.. . . ThissenD. (2000). Computerized adaptive testing: A primer (2nd ed.). New York, NY: Routledge.
61.
Williams-GrayC. H.FoltynieT.BrayneC. E.RobbinsT. W.BarkerR. A. (2007). Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain, 130, 1787-1798. doi:10.1093/brain/awm111
62.
Williams-GrayC. H.MasonS. L.EvansJ. R.FoltynieT.BrayneC.RobbinsT. W.BarkerR. A. (2013). The CamPaIGN study of Parkinson’s disease: 10-Year outlook in an incident population-based cohort. Journal of Neurology Neurosurgery & Psychiatry, 84, 1258-1264. doi:10.1136/jnnp-2013-305277
63.
ZadikoffC.FoxS. H.Tang-WaiD. F.ThomsenT.de BieR. M.WadiaP.. . . MarrasC. (2008). A comparison of the mini-mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson’s disease. Movement Disorders, 23, 297-299. doi:10.1002/mds.21837
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
